Steviol Glycoside Biosynthesis via Engineered Microbial Pathways
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for producing steviol glycosides, used as non-caloric sweeteners, face challenges such as low yields, the need for agronomic practices, high biomass requirements, and the presence of a bitter aftertaste, which limits their industrial and economic viability.
Innovation Solution
The development of DNA constructs that include genes for hexokinase, geranylgeranyl pyrophosphate synthase, 1-deoxy-D-xylulose-5-phosphate synthase, and other enzymes to enhance steviol glycoside production, eliminating the need for large growing fields and reducing organic solvent use, while avoiding bitter aftertastes through optimized biosynthesis pathways.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Quantity of substance
If traditional extraction methods are used to produce steviol glycosides, then the sweetener can be obtained, but the process requires large amounts of organic solvents and extensive purification steps
Solution Approach 1:
The patent replaces traditional mechanical extraction methods using organic solvents with a biological production system. Engineered microorganisms (yeast or bacteria) are used to biosynthesize steviol glycosides through metabolic engineering, eliminating the need for solvent-based extraction and extensive purification. The biological system converts simple substrates like glucose or sucrose directly into steviol glycosides through engineered enzymatic pathways.
2Quantity of substance
If plant-based production methods are used, then steviol glycosides can be obtained, but large growing fields and agronomic practices are required
Solution Approach 1:
The patent extracts the biosynthetic capability from whole plants and transfers it to microorganisms. By isolating and engineering the specific metabolic pathways (mevalonate pathway, non-mevalonate pathway) in yeast or bacteria, the production system is decoupled from agricultural requirements. This allows production in controlled bioreactors rather than large fields, maintaining the biochemical pathways while eliminating agronomic needs.
3Quantity of substance
If conventional steviol glycoside production is used, then sweetener is obtained, but a bitter aftertaste is produced
Solution Approach 1:
The patent applies local quality by engineering specific enzymatic activities in localized metabolic steps to produce desired glycoside profiles. By controlling which glycosyltransferases are expressed and their relative activities, the system produces predominantly sweet-tasting compounds (rebaudioside A, stevioside) while minimizing or eliminating bitter-tasting impurities. This precise control over molecular structure at specific pathway nodes achieves the desired sensory quality.
4Quantity of substance
If traditional production methods are used, then steviol glycosides can be obtained, but extensive purification is required to remove impurities
Solution Approach 1:
The patent implements self-service through engineered biosynthetic pathways that naturally produce high-purity steviol glycosides as the primary metabolic output. The engineered microorganisms are designed to channel metabolic flux preferentially toward desired products through pathway optimization, enzyme specificity, and regulatory mechanisms. This self-purifying approach minimizes the need for complex downstream processing equipment and operations.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach increases steviol glycoside production efficiency, reduces biomass requirements, and eliminates the bitter aftertaste, making them suitable for food, pharmaceutical, and nutritional supplement applications without the need for extensive purification.
Implementation Method 1
The mevalonate pathway is a metabolic pathway that produces the compounds isopentenyl pyrophosphate (IPP) and dimethylallyl pyrophosphate (DMAPP), which are used to make terpenes and sterols.
Implementation Method 2
The non-mevalonate pathway, also called the 1-deoxy-D-xylulose-5-phosphate (DXP) pathway or the 2-C-methyl-D-erythritol 4-phosphate (MEP) pathway, is a metabolic pathway that produces the compounds isopentenyl pyrophosphate (IPP) and dimethylallyl pyrophosphate (DMAPP).
Implementation Method 3
DNA constructs and methods for the production of steviol glycosides are provided. The DNA constructs can include a gene that expresses hexokinase, a gene that expresses geranylgeranyl pyrophosphate synthase, and a gene that expresses 1-deoxy-D-xylulose-5-phosphate synthase.
Data Source
AI summary
Described herein are devices and methods for increasing the production of steviol glycosides, which have industrial and economic value. The steviol glycosides produced by the devices and methods disclosed herein do not require the ultra purification that is common in conventional or commercial methods and do not have a bitter aftertaste, making them better suited as flavor-enhancing additives to food, pharmaceutical, and nutritional supplement products.